Get started
Author

Ami Fukumoto

Observed institution: Kameda Medical Center
ORCID: 0000-0002-1079-6888
Observed ORCID: 0000-0002-1079-6888
OpenAlex ID: A5077755061
Antibody response to COVID-19 vaccination in patients with lymphoma
2022 · Kentaro Narita, So Nakaji, et al. · International Journal of Hematology · 19
PDF
Antibody response to COVID-19 vaccine in 130 recipients of hematopoietic stem cell transplantation
2022 · Takafumi Tsushima, Toshiki Terao, et al. · International Journal of Hematology · 18
PDF
Carfilzomib-induced thrombotic microangiopathy is underestimated in clinical practice: A report of five patients and literature review
2022 · Toshiki Terao, Takafumi Tsushima, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 16
Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma
2022 · Toshiki Terao, Takeshi Yamashita, et al. · International Journal of Hematology · 14
PDF
Depletion of CD38 ‐positive regulatory T cells by anti‐CD38 monoclonal antibodies induces a durable response to SARS‐CoV ‐2 vaccination in patients with plasma cell dyscrasia
2022 · Toshiki Terao, Takashi Naduka, et al. · British Journal of Haematology · 14
Clinical and immunological characteristics of prolonged SARS-CoV-2 Omicron infection in hematologic disease
2023 · Daisuke Ikeda, Ami Fukumoto, et al. · Blood Cancer Journal · 12
PDF
Antibody status following booster vaccination against SARS‐CoV ‐2 virus in patients with haematologic malignancies
2022 · Daisuke Ikeda, Toshiki Terao, et al. · British Journal of Haematology · 9
Management of lymphoma-associated chylothorax by interventional radiology and chemotherapy: a report of five cases
2022 · Ami Fukumoto, Toshiki Terao, et al. · International Journal of Hematology · 8
Limited efficacy of high-dose methotrexate to prevent the central nervous system relapse in patients with IVLBCL
2022 · Toshiki Terao, Takafumi Tsushima, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 6
Impaired Antibody Response Following the Second Dose of the BNT162b2 Vaccine in Patients With Myeloproliferative Neoplasms Receiving Ruxolitinib
2022 · Daisuke Ikeda, Toshiki Terao, et al. · Frontiers in Medicine · 6
PDF
Association of loss of spleen visualization on whole-body diffusion-weighted imaging with prognosis and tumor burden in patients with multiple myeloma
2021 · Toshiki Terao, Youichi Machida, et al. · Scientific Reports · 6
PDF
Clinical Characteristics and Outcomes of Cyclin D1–Positive AL Amyloidosis
2023 · Takafumi Tsushima, Toshiki Terao, et al. · American Journal of Clinical Pathology · 5
PDF
EBV-PTLD in a patient after haploidentical stem-cell transplantation with post-transplant cyclophosphamide
2021 · Toshiki Terao, Takafumi Tsushima, et al. · International Journal of Hematology · 4
Safety and efficacy of venetoclax for acute myeloid leukaemia in real-world clinical practice
2023 · Ami Fukumoto, Kentaro Narita, et al. · Japanese Journal of Clinical Oncology · 3
PDF
Use of the Second Revision of the International Staging System for prognostic stratification of multiple myeloma patients in real-world clinical practice and the importance of sub-groups, including age
2023 · Yuka Uesugi, Daisuke Ikeda, et al. · Haematologica · 2
PDF
Concordance between HokUS-10 Scoring and Transjugular Liver Biopsy for the Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Allogeneic Stem Cell Transplantation
2023 · Ami Fukumoto, Koichi Honma, et al. · Transplantation and Cellular Therapy · 2
Kidney involvement of chronic active Epstein‐Barr virus infection
2023 · Ami Fukumoto, Shinnosuke Sugihara, et al. · eJHaem · 2
PDF
Successful allogeneic hematopoietic stem cell transplantation in a patient with acute myeloid leukemia and preexisting pulmonary nocardiosis
2022 · Ami Fukumoto, Daisuke Miura, et al. · Transplant Infectious Disease · 2
Carfilzomib Is Safe in Elderly Patients with Multiple Myeloma but Thrombotic Microangiopathy Is Underestimated in Clinical Practice
2021 · Toshiki Terao, Takafumi Tsushima, et al. · Blood · 2
P1137: Combined Metabolic Heterogeneity and Total Lesion Glycolysis From Pet-ct Improves the Prognostic Stratification in Patients With Peripheral T-cell Lymphoma
2023 · Daisuke Ikeda, Ami Fukumoto, et al. · HemaSphere
P1547: Clinical Characteristics of Patients With Prolonged Viral Shedding of Omicron Variant in Haematological Disease
2023 · Daisuke Ikeda, Kentaro Narita, et al. · HemaSphere
Prevalence and Clinical Outcome of Omicron Breakthrough Infection in Patients With Hematologic Disease: A Prospective Observational Cohort Study
2023 · Kentaro Narita, Daisuke Ikeda, et al. · HemaSphere
Humoral Response to the Third-Dose COVID-19 Vaccination in Patients with Hematological Malignancy
2022 · Daisuke Ikeda, Toshiki Terao, et al. · Blood
PDF
Prognostic Relevance of Tumor-Infiltrating T-Lymphocytes on Total Metabolic Tumor Volume-Based Risk Stratification of Patients with Diffuse Large B-Cell Lymphoma
2021 · Daisuke Ikeda, Kentaro Narita, et al. · Blood
Loss of Spleen Visualization on Whole-Body Diffusion-Weighted Imaging in Patients with Multiple Myeloma Is Associated with Poor Prognosis and High Tumor Burden
2021 · Toshiki Terao, Youichi Machida, et al. · Blood
Works count: 25
Citation count: 150
H-index: 8
I10-index: 6
Year
Topic
Type